Extracellular Vesicle Encapsulated MicroRNAs in Patients with Type 2 Diabetes Are Affected by Metformin Treatment
Recently, microRNAs (miRNAs) in circulating extracellular vesicles (EVs), have emerged as a source of potential biomarkers for various pathophysiological conditions, including metabolic disorders such as diabetes. Type 2 diabetes mellitus (T2DM), is the most prevalent form of diabetes in the USA, wi...
Main Authors: | Vikas Ghai, Taek-Kyun Kim, Alton Etheridge, Trine Nielsen, Torben Hansen, Oluf Pedersen, David Galas, Kai Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/5/617 |
Similar Items
-
Extracellular vesicles-mediated noncoding RNAs transfer in cancer
by: Pei Ma, et al.
Published: (2017-02-01) -
Selective release of circRNAs in platelet-derived extracellular vesicles
by: Christian Preußer, et al.
Published: (2018-12-01) -
Diverse RNAs in adipose-derived extracellular vesicles and their therapeutic potential
by: Pengyu Hong, et al.
Published: (2021-12-01) -
Release of extracellular vesicles containing small RNAs from the eggs of Schistosoma japonicum
by: Shanli Zhu, et al.
Published: (2016-11-01) -
Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged?
by: Fabio Seiti Yamada Yoshikawa, et al.
Published: (2019-06-01)